Phase II Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
Phase II Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of ONO-5129 in patients with type 2 diabetes mellitus.
Inclusion Criteria:
Exclusion Criteria:
Kanto, Japan
Kyusyu, Japan